Kaitlin Soye

Partner
  • she / her / hers
Admitted to the Ontario Bar: 2015

Print Bio

Instructions: Select the fields that you wish to include in the pdf generation.

% size of the Font for Generated PDF (Default is 80%)


  • Bio
  • Professional Involvement
  • Selected Speaking Engagements
  • Selected Publications
  • Education

Kaitlin is an intellectual property lawyer who enjoys collaborating with clients to develop effective IP strategies. As a trained scientist with a PhD in experimental medicine, she is adept at fusing legal and scientific principles to devise creative solutions to complex problems.

Kaitlin is a member of the firm’s Intellectual Property and Litigation & Dispute Resolution Groups. She represents a broad range of clients, including pharmaceutical, life sciences, technology and telecommunication companies, specifically with regulatory and IP litigation needs.

Kaitlin has extensive Federal Court experience and is efficient at managing the challenges that accompany complex litigation. She leverages her scientific background to represent life sciences and pharmaceutical industry clients in patent and regulatory disputes.

Professional Involvement

Memberships

  • Litigation Committee, Intellectual Property Institute of Canada, 2021-Present
  • Law Society of Ontario
  • The Advocates’ Society
  • Member-at-Large, Information Technology and Intellectual Property Law Executive, Ontario Bar Association
  • Toronto Intellectual Property Group
  • Mentorship Program, First Generation Network 

Selected Speaking Engagements

Presenter, “Anatomy of a Patent Trial,” ILCO’s Advanced Litigation Law CLE Program, November 20, 2019

Speaker, “OCI Demystified 2019,” Winsor Law’s OCI Demystified event, July 12, 2019

Selected Publications

Author, "Five Tips For Working With Self-Represented Litigants in IP Matters," Ontario Bar Association: Information Technology and Intellectual Property Law, February 25, 2023. 

Author, “Digging into the 2022 Federal Budget: Intellectual Property Issues,” Ontario Bar Association: Information Technology and Intellectual Property Law, May 7, 2022

Co-author, “Motions to Inspect Documents on Property,” Intellectual Property Litigation: Forms and Precedents, April 19, 2016

Co-author, “In vitro inhibition of mumps virus by retinoids,” Virology Journal, 2013 Nov 14;10:337, November 14, 2013

Co-author, “Genotype-driven recruitment: a strategy whose time has come?,” BMC Med Genomics 6, 19, May 23, 2013

Co-author, “RIG-I is required for the inhibition of measles virus by retinoids,” PLOS ONE 6(7) July 19, 2011

Co-author, “In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication,” RNA Biol 2011, March 1, 2011

Co-author, “Inhibition of HIV-1 expression and replication by SOFA-HDV ribozymes against Tat and Rev mRNA sequences,” Retrovirology 2009, September 24, 2009

Co-author, “Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production,” Virology Journal, March 14, 2007

Education

  • LLB/BCL, McGill University, 2014
  • PhD, Experimental Medicine, McGill University, 2011
  • Graduate Certificate, Business Administration, Concordia University, 2010
  • MSc, Microbiology and Immunology, McGill University, 2007
  • B.Sc. (Hons.), Molecular Biology and Genetics, University of Guelph, 2005 

Expertise

Intellectual Property
Litigation & Dispute Resolution